WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 8 fonti

UK approves Novo weight-loss pill to edge open European market

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatment. Over 10 million people with obesity in the UK now have an alternative to injections. Drugmakers are racing to expand use of these transformative medicines. The market is expected to reach over 100 billion dollars by 2030.

Raccontata dadailymail.commirror.co.uktheguardian.combenzinga.comeconomictimes.indiatimes.comindependent.co.uknewsbytesapp.comcnbc.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
economictimes.indiatimes.comStai leggendo5 g fa

UK approves Novo weight-loss pill to edge open European market

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatment. Over 10 million people with obesity in the UK now have an alternative to…

originale
newsbytesapp.com5 g fa

UK approves first weight-loss pill as alternative to injections

Britain's regulator has approved Novo Nordisk's weight-loss pill, marking the UK's entry as the first European market for this oral obesity treatment.

Leggi questa versione → originale
benzinga.com6 g fa

Novo Nordisk Advances Weight-Loss Portfolio With UK Approval Of Wegovy Tablet - Novo Nordisk (NYSE:NVO)

Novo Nordisk wins U.K. approval for Wegovy pill, offering adults a daily oral weight-loss option backed by Phase 3 trial data.

Leggi questa versione → originale
mirror.co.uk6 g fa

Breakthrough as UK's first weight loss tablet is given green light

Novo Nordisk riceve approvazione UK per Wegovy orale: 25mg giornalieri, primo GLP-1 in pillola; trial mostra 17% perdita di peso media vs 3% placebo dopo 64 settimane. Amplia l'accesso ai trattamenti obesity, segnalando opportunità per digital health e telemedicine nel monitoraggio.

Leggi questa versione → originale
independent.co.uk5 g fa

Wegovy becomes first daily weight loss pill to be approved in UK

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be…

Leggi questa versione → originale
dailymail.com6 g fa

Wegovy Pill weight-loss drug approved for use in Britain

As exclusively revealed by the Daily Mail last week, the Wegovy Pill - the tablet form of the once-weekly Wegovy injection - has been greenlit by health officials.

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 11 giugno 2026·dailymail.com

    Wegovy Pill weight-loss drug approved for use in Britain

    As exclusively revealed by the Daily Mail last week, the Wegovy Pill - the tablet form of the once-weekly Wegovy injection - has been greenlit by health officials.

  2. giovedì 11 giugno 2026·mirror.co.uk

    Breakthrough as UK's first weight loss tablet is given green light

    A new prescription-only weight loss tablet has been approved for use in the UK for people who are overweight and have a related condition like high blood pressure

  3. giovedì 11 giugno 2026·theguardian.com

    Wegovy weight-loss pills to be available for patients in UK to buy

    Regulator approval means patients who meet criteria such as having obesity will be able to purchase pills with private prescription

  4. giovedì 11 giugno 2026·benzinga.com

    Novo Nordisk Advances Weight-Loss Portfolio With UK Approval Of Wegovy Tablet - Novo Nordisk (NYSE:NVO)

    Novo Nordisk wins U.K. approval for Wegovy pill, offering adults a daily oral weight-loss option backed by Phase 3 trial data.

  5. venerdì 12 giugno 2026·economictimes.indiatimes.com

    UK approves Novo weight-loss pill to edge open European market

    Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatment. Over 10 million people with obesity…

  6. venerdì 12 giugno 2026·independent.co.uk

    Wegovy becomes first daily weight loss pill to be approved in UK

    Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

  7. venerdì 12 giugno 2026·newsbytesapp.com

    UK approves first weight-loss pill as alternative to injections

    Britain's regulator has approved Novo Nordisk's weight-loss pill, marking the UK's entry as the first European market for this oral obesity treatment.

  8. venerdì 12 giugno 2026·mirror.co.uk

    New Wegovy diet pill approved - who qualifies and how to get it

    Health chiefs have given the go-ahead for a tablet form of the weight loss drug to be used in the UK - full details of who can get it, how and when it will be available

  9. sabato 13 giugno 2026·cnbc.com

    Drugmakers race to find a place in the next wave of obesity drugs

    Drugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.